<DOC>
	<DOCNO>NCT00004404</DOCNO>
	<brief_summary>OBJECTIVES : Determine effectiveness combine use clotrimazole hydroxyurea specific panel red cell characteristic patient sickle cell syndrome .</brief_summary>
	<brief_title>Study Clotrimazole Hydroxyurea Patients With Sickle Cell Syndromes</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive oral hydroxyurea either twice daily plus oral clotrimazole twice daily meal 6 month . Patients assess 3 6 month treatment . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Sickle cell syndrome characterize vasoocclusive crisis sufficiently severe require prophylactic therapy Three crisis per year sufficiently severe require hospitalization Stable dose hydroxyurea least 4 month require Prior/Concurrent Therapy No treatment antisickling agent within past 4 month Biologic therapy : No transfusion within 90 day No concurrent chronic transfusion allow ( defined one transfusion per month 2 month ) Chemotherapy : See Disease Characteristics Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : No chronic medication alter neurologic , renal , hepatic function Patient Characteristics Performance status : Karnofsky 70100 % Hematopoietic : WBC within normal limit Platelet count within normal limit Hepatic : No history chronic liver disease Bilirubin le 2 time normal SGOT SGPT less 2.5 time normal No severe hepatic damage Renal : Creatinine within normal limit No severe renal damage Neurologic : No severe neurologic impairment No recent progressive neurologic impairment Other : Not pregnant Fertile patient must use effective contraception No allergy hydroxyurea clotrimazole</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1998</verification_date>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>hematologic disorder</keyword>
	<keyword>rare disease</keyword>
	<keyword>sickle cell anemia</keyword>
</DOC>